Page last updated: 2024-08-24

topotecan and Lymphoma, Non-Hodgkin

topotecan has been researched along with Lymphoma, Non-Hodgkin in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (20.00)	18.2507
2000's	12 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Couban, S; Crump, M; Eisenhauer, E; Gluck, S; Hoskins, P; Maksymiuk, A; Matthews, S; Meyer, R; Rudinskas, L; Zanke, B	1
Fu, ZZ; Ma, R; Qiu, HY; Ruan, CG; Sun, AN; Tang, XW; Wu, DP	1
Fischer, L; Jahnke, K; Kirchen, H; Klasen, HA; Korfel, A; Thiel, E	1
Coutinho, F; Del Giglio, A; Manhani, AR; Velasquez, WS	1
Fayad, L; Goy, A; Hagemeister, FB; Loyer, E; McLaughlin, P; Pro, B; Rodriguez, MA; Romaguera, J; Younes, A	1
Bartlett, NL; Canellos, G; Cheson, BD; Eder, JP; Johnson, JL; Niedzwiecki, D; Smith, SM	1
Coutinho, F; Dantas, AA; Del Giglio, A; Manhani, AR	1
Batchelor, T; Betensky, R; Hochberg, F; Voloschin, AD; Wen, PY	1
Kraut, E; Muller, MT; Staubus, A; Subramanian, D; Young, DC	1
Cabanillas, F	1
Ahmed, T; Durrani, H; Kancherla, RR; Mannancheril, A; Nair, JS; Seiter, K; Tse-Dinh, YC	1
Kancherla, R; Nair, JS; Seiter, K; Traganos, F; Tse-Dinh, YC	1
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Palmer, JL; Preti, HA; Rodriguez, MA; Romaguera, JE; Samuels, BI; Younes, A	1
Balcerzak, SP; Davis, MP; Jacobs, SA; Kraut, EH; Young, D	1

Reviews

1 review(s) available for topotecan and Lymphoma, Non-Hodgkin

Article	Year
The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphoma. Seminars in hematology, 1999, Volume: 36, Issue:4 Suppl 8 Topics: Antineoplastic Combined Chemotherapy Protocols; Enzyme Inhibitors; Humans; Lymphoma, Non-Hodgkin; Paclitaxel; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan	1999

Trials

11 trial(s) available for topotecan and Lymphoma, Non-Hodgkin

Article	Year
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study. Leukemia & lymphoma, 2002, Volume: 43, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Topotecan	2002
Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan. Neurology, 2004, May-25, Volume: 62, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prospective Studies; Remission Induction; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome	2004
Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing lymphomas: results of a phase I trial. Acta haematologica, 2004, Volume: 112, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Glucocorticoids; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence; Topotecan; Treatment Outcome	2004
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma, 2006, Volume: 47, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Injections, Subcutaneous; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutrophils; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Recurrence; Topotecan; Treatment Outcome	2006
Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leukemia & lymphoma, 2006, Volume: 47, Issue:8 Topics: Adult; Aged; Burkitt Lymphoma; Disease-Free Survival; Doxorubicin; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Remission Induction; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan	2006
Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial. Acta haematologica, 2006, Volume: 116, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Analysis; Topotecan	2006
Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma. Journal of neuro-oncology, 2008, Volume: 86, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Topotecan; Treatment Outcome	2008
Analysis of topoisomerase I/DNA complexes in patients administered topotecan. Cancer research, 1995, May-15, Volume: 55, Issue:10 Topics: Antineoplastic Agents; Camptothecin; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; HeLa Cells; Humans; Lymphoma, Non-Hodgkin; Melanoma; Topotecan	1995
Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response. Cancer, 2001, Feb-01, Volume: 91, Issue:3 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Humans; Isoenzymes; Lymphoma, Non-Hodgkin; Male; Middle Aged; RNA, Messenger; Topotecan; Treatment Outcome	2001
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:7 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutrophils; Paclitaxel; Topotecan; Treatment Outcome	2001
A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study. Cancer investigation, 2002, Volume: 20, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Topoisomerase I Inhibitors; Topotecan	2002

Other Studies

3 other study(ies) available for topotecan and Lymphoma, Non-Hodgkin

Article	Year
[Topotecan-based combined chemotherapy for refractory or relapsed hematologic malignancies]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2003, Volume: 25, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Topotecan	2003
Action of topoisomerase targeting drugs on non-Hodgkin's lymphoma and leukemia. Correlation of clinical and cell culture studies. Annals of the New York Academy of Sciences, 2000, Volume: 922 Topics: Acute Disease; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Cytarabine; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Isoenzymes; Leukemia; Leukocytes; Lymphoma, Non-Hodgkin; Mitoxantrone; Polymerase Chain Reaction; RNA, Messenger; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan	2000
Lymphoma trials recruiting. AIDS patient care and STDs, 1998, Volume: 12, Issue:4 Topics: Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Lymphoma, Non-Hodgkin; Patient Selection; Spermine; Topotecan	1998